Skip to main content
OpenTrials
Completed

NCT Number: NCT00898482

Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

RATIONALE: Collecting and storing samples of blood from patients with cancer and healthy participants to test in the laboratory may help the study of cancer in the future.

PURPOSE: This study is collecting and storing samples of blood from patients with pancreatic cancer and healthy participants.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pancreatic Cancer Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Neoplasms Neoplasms by Site Pancreatic Diseases Pancreatic Neoplasms

Age range

18 year–120 year

Sex eligibility

All sexes

Study type

Observational

About this study

OBJECTIVES:

  • Establish a central pancreatic cancer specimen (including serum and peripheral blood lymphocytes) repository to serve as a resource for current or future scientific studies.
  • Utilize the clinical database to perform clinicopathologic correlation with the results of those studies.
  • Test new hypotheses as they emerge.

OUTLINE: This is a prospective study.

Blood is collected from patients with pancreatic cancer at baseline and then every 3-6 months for up to 2 years. All other participants have blood collected at baseline and complete questionnaires at baseline and then every 3-6 months for up to 2 years. Serum and peripheral blood lymphocytes obtained from the blood samples are frozen and stored.

PROJECTED ACCRUAL: A total of 200 patients and 200 other participants will be accrued for this study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

DISEASE CHARACTERISTICS:

  • Meets 1 of the following criteria:
  • Histologically confirmed pancreatic malignant neoplasm
  • Serologically or image-confirmed diagnosis of pancreatitis or nonmalignant pancreatic disease
  • Healthy, at-risk participant meeting the following criteria:
  • Smoker, diabetic, and/or has a family history of pancreatic cancer
  • Healthy participant (no history of cancer)

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified

Treatment and study plan

This is a non-intervention study for all groups.

Other

This is a non-intervention study.

study of socioeconomic and demographic variables

Other

Non-intervention study.

Primary outcomes

  1. Establishment of a central pancreatic cancer specimen repository

    Time frame: No time frame

  2. Utilization of the clinical database to perform clinicopathologic correlation with the results of current or future scientific studies

    Time frame: No time frame

  3. Test new hypotheses as they emerge

    Time frame: No time frame

Sponsors and collaborators

Lead sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Pancreatic Cancer Serum and Peripheral Blood Lymphocyte Repository

Important dates

Study start
2005
Primary completion
2011
Study completion
2011
First posted
May 12, 2009
Registry last updated
Nov 20, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.